{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1415","meta":{"versionId":"5","lastUpdated":"2017-05-04T01:00:13.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2017-05-04"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1415","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.196.11.1415"}],"version":"20170504","name":"HydrochlorothiazideMethyldopa","title":"Hydrochlorothiazide / Methyldopa","status":"active","experimental":false,"date":"2017-05-04T01:00:13-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"197960","display":"Hydrochlorothiazide 25 MG / Methyldopa 250 MG Oral Tablet"},{"code":"197963","display":"Hydrochlorothiazide 15 MG / Methyldopa 250 MG Oral Tablet"}]}]},"expansion":{"identifier":"urn:uuid:e86394c2-3b33-451a-b926-774c46ddbbde","timestamp":"2023-12-11T02:32:52-05:00","total":2,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"197960","display":"hydrochlorothiazide 25 MG / methyldopa 250 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"197963","display":"hydrochlorothiazide 15 MG / methyldopa 250 MG Oral Tablet"}]}}